400 related articles for article (PubMed ID: 32308746)
1. Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing.
Shi J; Zhang R; Li J; Zhang R
Theranostics; 2020; 10(11):4737-4748. PubMed ID: 32308746
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of fetal and maternal long cell-free DNA fragments from maternal plasma following DNA repair.
Vong JSL; Jiang P; Cheng SH; Lee WS; Tsang JCH; Leung TY; Chan KCA; Chiu RWK; Lo YMD
Prenat Diagn; 2019 Jan; 39(2):88-99. PubMed ID: 30575063
[TBL] [Abstract][Full Text] [Related]
3. Cell-Free DNA: Applications in Different Diseases.
Ranucci R
Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
[TBL] [Abstract][Full Text] [Related]
4. The fragmentation patterns of maternal plasma cell-free DNA and its applications in non-invasive prenatal testing.
Pan M; Chen P; Lu J; Liu Z; Jia E; Ge Q
Prenat Diagn; 2020 Jul; 40(8):911-917. PubMed ID: 32147843
[TBL] [Abstract][Full Text] [Related]
5. Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients.
Neuberger EWI; Brahmer A; Ehlert T; Kluge K; Philippi KFA; Boedecker SC; Weinmann-Menke J; Simon P
Sci Rep; 2021 Jun; 11(1):13581. PubMed ID: 34193884
[TBL] [Abstract][Full Text] [Related]
6. Improving the accuracy of noninvasive prenatal testing through size-selection between fetal and maternal cfDNA.
Kwon HJ; Yun S; Joo J; Park D; Do WJ; Lee S; Lee MS
Prenat Diagn; 2023 Dec; 43(13):1581-1592. PubMed ID: 37975672
[TBL] [Abstract][Full Text] [Related]
7. High levels of circulating cell-free DNA are a biomarker of active SLE.
Xu Y; Song Y; Chang J; Zhou X; Qi Q; Tian X; Li M; Zeng X; Xu M; Zhang W; Cram DS; Liu J
Eur J Clin Invest; 2018 Nov; 48(11):e13015. PubMed ID: 30079480
[TBL] [Abstract][Full Text] [Related]
8. Potentially effective method for fetal gender determination by noninvasive prenatal testing for X-linked disease.
Noda Y; Kato T; Kato A; Nishizawa H; Miyazaki J; Ito M; Terasawa S; Sekiya T; Fujii T; Kurahashi H
Congenit Anom (Kyoto); 2019 May; 59(3):88-92. PubMed ID: 29926512
[TBL] [Abstract][Full Text] [Related]
9. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
[TBL] [Abstract][Full Text] [Related]
10. An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study.
Hu P; Liang D; Chen Y; Lin Y; Qiao F; Li H; Wang T; Peng C; Luo D; Liu H; Xu Z
J Transl Med; 2019 Apr; 17(1):124. PubMed ID: 30975179
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Pipeline for Accurate Quantification of Fetal DNA Fraction in Maternal Plasma.
Ni M; Peng XL; Jiang P
Methods Mol Biol; 2019; 1909():177-180. PubMed ID: 30580431
[TBL] [Abstract][Full Text] [Related]
12. Concentration of cell-free DNA in different tumor types.
Bryzgunova OE; Konoshenko MY; Laktionov PP
Expert Rev Mol Diagn; 2021 Jan; 21(1):63-75. PubMed ID: 33270495
[No Abstract] [Full Text] [Related]
13. Cell-free DNA profiling in patients with lupus nephritis.
Truszewska A; Wirkowska A; Gala K; Truszewski P; Krzemień-Ojak Ł; Perkowska-Ptasińska A; Mucha K; Pączek L; Foroncewicz B
Lupus; 2020 Nov; 29(13):1759-1772. PubMed ID: 32924831
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide detection of additional fetal chromosomal abnormalities by cell-free DNA testing of 15,626 consecutive pregnant women.
Yao H; Gao Y; Zhao J; Zhang R; Xu H; Hu H; Luo Y; Yuan Y; Fu M; Zhang H; Jiang H; Wang W; Yang H; Wang J; Liang Z; Chen F
Sci China Life Sci; 2019 Feb; 62(2):215-224. PubMed ID: 30076564
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and statistical optimization of a method for methylated cell-free fetal DNA extraction from maternal plasma.
Akbariqomi M; Heidari R; Gargari SS; Omrani MD; Rigi G; Sanikhani NS; Kooshki H; Mahmoudian F; Mazlomi MA; Tavoosidana G
J Assist Reprod Genet; 2019 May; 36(5):1029-1038. PubMed ID: 30820784
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative comparison of cell-free DNA and cell-free fetal DNA isolation by four (semi-)automated extraction methods: impact in two clinical applications: chimerism quantification and noninvasive prenatal diagnosis.
Pedini P; Graiet H; Laget L; Filosa L; Chatron J; Cherouat N; Chiaroni J; Hubert L; Frassati C; Picard C
J Transl Med; 2021 Jan; 19(1):15. PubMed ID: 33407582
[TBL] [Abstract][Full Text] [Related]
17. Cell free DNA: revolution in molecular diagnostics - the journey so far.
Nandi K; Verma R; Dawar R; Goswami B
Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32083442
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation.
Sherwood K; Weimer ET
J Immunol Methods; 2018 Dec; 463():27-38. PubMed ID: 30267663
[TBL] [Abstract][Full Text] [Related]
20. The personal utility of cfDNA screening: Pregnant patients' experiences with cfDNA screening and views on expanded cfDNA panels.
Farrell RM; Agatisa PK; Michie MM; Greene A; Ford PJ
J Genet Couns; 2020 Feb; 29(1):88-96. PubMed ID: 31680382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
